Weideman William H
Known title: DirectorCIK: 0001359647
Associated companies
Transaction History
| OLN | ▲ Buy | Grant | 761 | $40K | 5/1/2024 | View on chart |
| OLN | ▲ Buy | Grant | 727 | $40K | 5/1/2023 | View on chart |
| OLN | ▲ Buy | Grant | 679 | $40K | 5/2/2022 | View on chart |
| OLN | ▲ Buy | Grant | 761 | $40K | 5/1/2024 | View on chart |
| OLN | ▲ Buy | Grant | 727 | $40K | 5/1/2023 | View on chart |
| OLN | ▲ Buy | Grant | 679 | $40K | 5/2/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
UBS Cuts Olin Target to $18, Awaits Q3 Earnings
UBS has lowered its price target for Olin to $18 while maintaining a Neutral rating. This move comes just ahead of the company's Third Quarter 2026 earnings conference call. The stock is currently trading near its 52-week low, with an average analyst target of $20.20.
UBS Cuts Olin Target to $18, Awaits Q3 Earnings. UBS has lowered its price target for Olin to $18 while maintaining a Neutral rating. This move comes just ahead of the company's Third Quarter 2026 earnings conference call. The stock is currently trading near its 52-week low, with an average analyst target of $20.20.